Colgate-Palmolive (CL) Stock Forecast & Price Target $94.10 -3.29 (-3.37%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$93.98 -0.12 (-0.13%) As of 10/23/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 20 Analyst RatingsSell0Hold7Buy13 Based on 20 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 7 have given a hold rating, and 13 have given a buy rating for CL. Consensus Price Target $98.004.14% Upside According to the 20 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $98.00. The highest price target for CL is $110.00, while the lowest price target for CL is $87.00. The average price target represents a forecasted upside of 4.14% from the current price of $94.10. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for CL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CL Analyst Ratings Over TimeTypeCurrent Forecast10/25/25 to 10/25/261 Month Ago9/25/25 to 9/25/263 Months Ago7/27/25 to 7/27/261 Year Ago10/25/24 to 10/25/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy13 Buy rating(s)13 Buy rating(s)12 Buy rating(s)8 Buy rating(s)Hold7 Hold rating(s)6 Hold rating(s)7 Hold rating(s)5 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)1 Sell rating(s)Consensus Price Target$98.00$98.50$97.44$91.50Forecasted Upside4.14% Upside14.47% Upside5.92% Upside17.30% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy CL Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CL Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Colgate-Palmolive Stock vs. The CompetitionTypeColgate-PalmoliveConsumer Staples CompaniesBroader MarketConsensus Rating Score 2.65 2.23 2.53Consensus RatingModerate BuyHoldModerate BuyPredicted Upside4.14% Upside151.62% Upside16.92% UpsideNews Sentiment RatingPositive NewsSee Recent CL NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings Most Recent from Each Brokerage All Show All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action 10/25/2024 - 10/25/2026 Report Date Report Date From Report Date To 1M3M6MYTD1Y2Y3Y5Y More filters Fewer filters Done 0 Results Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/19/2026 JPMorgan Chase & Co.3 of 5 starsAndrea Teixeira3 of 5 starsBoost TargetOverweight$103.00 ➝ $104.00+11.31%10/15/2026 UBS Group4 of 5 starsPeter Grom2 of 5 starsSet Target$106.00+13.93%10/9/2026 Bank of America4 of 5 starsBryan Spillane1 of 5 starsLower TargetBuy$102.00 ➝ $100.00+13.39%10/8/2026 EvercoreSubscribe to MarketBeat All Access to unlock brokerage rankings Boost TargetOutperform$100.00 ➝ $101.00+14.52%10/5/2026 Wells Fargo & CompanySubscribe to MarketBeat All Access to unlock brokerage rankingsChris CareySubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetEqual Weight$95.00 ➝ $90.00+5.00%10/2/2026 Weiss RatingsSubscribe to MarketBeat All Access to unlock brokerage rankings DowngradeBuy (B-) ➝ Hold (C+)9/28/2026 BNP Paribas ExaneSubscribe to MarketBeat All Access to unlock brokerage rankings Lower TargetOutperform$101.00 ➝ $97.00+9.98%9/21/2026 Piper SandlerSubscribe to MarketBeat All Access to unlock brokerage rankingsMichael LaverySubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetOverweight$98.00 ➝ $95.00+8.57%9/8/2026 Royal Bank Of CanadaSubscribe to MarketBeat All Access to unlock brokerage rankingsNik ModiSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingOutperform$104.00+17.54%8/13/2026 Sanford C. BernsteinSubscribe to MarketBeat All Access to unlock brokerage rankingsCristian RiosSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingMarket Perform Get the Latest News and Ratings for CL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter. 8/3/2026 Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access to unlock brokerage rankingsSteve PowersSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingBuy$99.00 ➝ $101.00+10.42%8/3/2026 Morgan StanleySubscribe to MarketBeat All Access to unlock brokerage rankingsDara MohsenianSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingOverweight$100.00 ➝ $104.00+12.06%8/3/2026 TD CowenSubscribe to MarketBeat All Access to unlock brokerage rankingsRobert MoskowSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetHold$85.00 ➝ $90.00-3.03%8/3/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingHold$88.00 ➝ $89.00-2.51%8/3/2026 Raymond James FinancialSubscribe to MarketBeat All Access to unlock brokerage rankings Boost TargetOutperform$100.00 ➝ $102.00+15.65%7/21/2026 BarclaysSubscribe to MarketBeat All Access to unlock brokerage rankingsLauren LiebermanSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetEqual Weight$80.00 ➝ $87.00-5.36%7/14/2026 CitigroupSubscribe to MarketBeat All Access to unlock brokerage rankingsFilippo FalorniSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetBuy$105.00 ➝ $110.00+18.09%5/1/2026 The Goldman Sachs GroupSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingBuy$100.00 ➝ $98.00+12.45%4/21/2026 Rothschild & Co RedburnSubscribe to MarketBeat All Access to unlock brokerage rankingsEdward LewisSubscribe to MarketBeat All Access to unlock analyst rankingsSet TargetNeutral ➝ Buy$93.00 ➝ $100.00+19.78%12/11/2025 ArgusSubscribe to MarketBeat All Access to unlock brokerage rankingsTaylor ConradSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingBuy ➝ Hold10/30/2025 HSBCSubscribe to MarketBeat All Access to unlock brokerage rankings Lower Target$92.00 ➝ $88.00-0.22%2/3/2025 Stifel NicolausSubscribe to MarketBeat All Access to unlock brokerage rankingsMark AstrachanSubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetHold$95.00 ➝ $93.00+7.86%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:49 PM ET. Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, October 24, 2026. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com. Colgate-Palmolive Bull Case Here are some ways that investors could benefit from investing in Colgate-Palmolive: Colgate-Palmolive shares are currently trading at $94.10, which is below the average analyst price target of $98.00, suggesting potential upside for investors who believe the market is undervaluing the company's defensive stability and global footprint. The company demonstrated strong recent performance by beating consensus estimates in its latest quarterly report, posting earnings per share of $0.99 against an expected $0.95, while also achieving 4.9% year-over-year revenue growth, indicating that its core business remains resilient despite macroeconomic headwinds. With a beta of 0.33, Colgate-Palmolive offers significantly lower volatility than the broader market, making it an attractive defensive holding for investors seeking stability and income preservation during periods of market uncertainty or economic slowdowns. The stock provides a consistent income stream with a dividend yield of 2.18%, supported by a recent declaration of a $0.53 quarterly dividend, which appeals to income-focused investors looking for reliable cash flow from a established consumer staples brand. Institutional interest remains robust, with major investors like State Street Corp and Bank of New York Mellon Corp significantly increasing their holdings in recent quarters, signaling confidence in the company's long-term value proposition and brand strength in oral and personal care. Colgate-Palmolive Bear Case Investors should be bearish about investing in Colgate-Palmolive for these reasons: Management has warned that volatile market conditions, including raw material and packaging inflation and tariff effects, are expected to persist through the rest of 2026, posing ongoing risks to profit margins and operational costs. Insider sentiment appears cautious, as corporate insiders have executed five open-market sales and no purchases over the past six months, including significant share reductions by CEO Noel Wallace, which may weigh on investor confidence. Recent options activity shows unusual put buying, with 4,443 put contracts purchased—71% above typical volume—indicating that some market participants are hedging against or positioning for a potential decline in the stock price ahead of upcoming earnings. The company faces intense category competition and pressure on consumer spending, which could impact future demand and product mix, particularly as consumers become more price-sensitive in the household and personal care sectors. Valuation metrics such as a P/E ratio of 37.34 suggest the stock may be priced for perfection, leaving little room for error if earnings growth slows or if the company fails to meet the high expectations set by analysts and institutional investors. CL Forecast - Frequently Asked Questions What is Colgate-Palmolive's forecast for 2026? According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $98.00, with a high forecast of $110.00 and a low forecast of $87.00. Should I buy or sell Colgate-Palmolive stock right now? 20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 7 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CL shares. Does Colgate-Palmolive's stock price have much upside? According to analysts, Colgate-Palmolive's stock has a predicted upside of 4.14% based on their 12-month stock forecasts. Has Colgate-Palmolive been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Colgate-Palmolive's stock had 1 upgrade and 1 downgrade by analysts. What analysts cover Colgate-Palmolive? Colgate-Palmolive has been rated by research analysts at Bank of America, BNP Paribas Exane, Deutsche Bank Aktiengesellschaft, Evercore, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Raymond James Financial, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Colgate-Palmolive more than its competitors? Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies. Stock Forecasts and Research Tools Related Companies Interparfums Stock Forecast Kimberly-Clark Stock Forecast Mondelez International Stock Forecast Church & Dwight Stock Forecast Clorox Stock Forecast CocaCola Stock Forecast Procter & Gamble Stock Forecast Reynolds Consumer Products Stock Forecast WD-40 Stock Forecast Central Garden & Pet Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Colgate-Palmolive RecommendationsJPMorgan Chase & Co.UBS GroupBank of AmericaEvercoreWells Fargo & CompanyWeiss RatingsBNP Paribas ExanePiper SandlerRoyal Bank Of CanadaSanford C. BernsteinMorgan StanleyDeutsche Bank AktiengesellschaftTD CowenJefferies Financial GroupRaymond James Financial MarketBeat monitors more than a dozen sources for Colgate-Palmolive analyst ratings, with the most recent rating issued on 10/19/2026. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Colgate-Palmolive Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Colgate-Palmolive With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.